NOVELTY, DOPAMINE AND RESPONSE TO AMPHETAMINE

新奇、多巴胺和对安非他明的反应

基本信息

  • 批准号:
    6038222
  • 负责人:
  • 金额:
    $ 21.34万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2000
  • 资助国家:
    美国
  • 起止时间:
    2000-03-01 至 2003-02-28
  • 项目状态:
    已结题

项目摘要

Our overall working hypothesis is that exposure to novel stimuli activates the mesolimbic dopamine (DA) reward pathway in a manner similar to drugs of abuse. In support of this hypothesis, we now have clear neurochemical evidence that novelty activates the mesolimbic DA system in rats. At the behavioral level, we also found that rats raised from weaning in an environment enriched with novel stimuli show a reduction in intravenous amphetamine self-administration as adults compared to rats raised in isolation. However, it is not known if the reduction in amphetamine self-administration reflects an environment-induced alteration in mesolimbic DA activity, nor is it known if brief exposure to novelty during young adulthood will also reduce amphetamine self-administration. The present project will determine if environmental enrichment during development alters mesolimbic DA activity. In vivo voltammetry and electrophysiological recording techniques, as well as in vitro cellular techniques, will be used to answer this question. These neurochemical experiments will begin with the nucleus accumbens, although other brain regions (e.g., prefrontal cortex, extended amygdala, hippocampus) will be examined in later studies. At the behavioral level, environment-induced differences in amphetamine self-administration will be examined using both fixed ratio and progressive ratio schedules of reinforcement. Control experiments will determine if environment-induced differences observed with amphetamine self- administration generalize to sucrose reinforcement. Finally, we will examine if brief exposure to novelty during young adulthood also reduces amphetamine self-administration. Based on our working hypothesis, we predict that novelty will substitute for amphetamine reward. If novelty reduces amphetamine self-administration in rats, this preclinical information would provide the impetus for examining the effectiveness of presenting highly novel stimulation in drug abuse prevention and/or treatment interventions in humans. The long-term objective of this work is to design a biologically relevant prevention intervention strategy that can be evaluated in a controlled human study.
我们的总体工作假设是,暴露在新的刺激下,以类似于滥用药物的方式激活中脑边缘多巴胺(DA)奖励途径。为了支持这一假说,我们现在有明确的神经化学证据表明,新奇事物激活了大鼠的中脑边缘DA系统。在行为水平上,我们还发现,在富含新刺激的环境中断奶饲养的大鼠,成年后静脉注射苯丙胺的次数比在隔离环境中饲养的大鼠要少。然而,目前尚不清楚苯丙胺自我给药的减少是否反映了环境诱导的中脑边缘多巴胺活动的改变,也不知道青年时期短暂接触新奇事物是否也会减少安非他明的自我给药。本项目将确定在发育过程中环境的丰富是否会改变中边缘DA的活动。体内伏安法和电生理记录技术,以及体外细胞技术,将被用来回答这个问题。这些神经化学实验将从伏隔核开始,但其他大脑区域(如前额叶皮质、延伸的杏仁核、海马体)将在以后的研究中进行检查。在行为水平上,环境诱导的苯丙胺自我给药差异将使用固定比率和累进比率强化表来检验。对照实验将确定苯丙胺自身给药观察到的环境诱导的差异是否推广到蔗糖强化。最后,我们将研究青年时期短暂接触新奇事物是否也会降低苯丙胺的自我管理能力。根据我们的工作假设,我们预测新鲜感将取代安非他明奖励。如果新颖性减少了大鼠的苯丙胺自我给药,这一临床前信息将为检验在人类药物滥用预防和/或治疗干预中呈现高度新颖的刺激的有效性提供动力。这项工作的长期目标是设计一种生物相关的预防干预策略,可以在受控的人类研究中进行评估。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Michael T Bardo其他文献

Michael T Bardo的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Michael T Bardo', 18)}}的其他基金

Functional and Genomic Signatures of Escalated Fentanyl Use
芬太尼使用升级的功能和基因组特征
  • 批准号:
    10364661
  • 财政年份:
    2021
  • 资助金额:
    $ 21.34万
  • 项目类别:
Functional and Genomic Signatures of Escalated Fentanyl Use
芬太尼使用升级的功能和基因组特征
  • 批准号:
    10549836
  • 财政年份:
    2021
  • 资助金额:
    $ 21.34万
  • 项目类别:
Functional and Genomic Signatures of Escalated Fentanyl Use
芬太尼使用升级的功能和基因组特征
  • 批准号:
    10154082
  • 财政年份:
    2021
  • 资助金额:
    $ 21.34万
  • 项目类别:
Social Cues and Drug Relapse
社会暗示和药物复发
  • 批准号:
    9245436
  • 财政年份:
    2017
  • 资助金额:
    $ 21.34万
  • 项目类别:
INDIVIDUAL DIFFERENCES IN RESPONSE TO AMPHETAMINE
对安非他明反应的个体差异
  • 批准号:
    7389818
  • 财政年份:
    2007
  • 资助金额:
    $ 21.34万
  • 项目类别:
CORE
  • 批准号:
    7389817
  • 财政年份:
    2007
  • 资助金额:
    $ 21.34万
  • 项目类别:
Nornicotine Enantiomers and Nicotine Self Administration
降烟碱对映体和尼古丁自我给药
  • 批准号:
    6644050
  • 财政年份:
    2003
  • 资助金额:
    $ 21.34万
  • 项目类别:
Nornicotine as a Treatment for Nicotine Addiction
去甲尼古丁治疗尼古丁成瘾
  • 批准号:
    7121533
  • 财政年份:
    2003
  • 资助金额:
    $ 21.34万
  • 项目类别:
Nornicotine as a Treatment for Nicotine Addiction
去甲尼古丁治疗尼古丁成瘾
  • 批准号:
    6891732
  • 财政年份:
    2003
  • 资助金额:
    $ 21.34万
  • 项目类别:
NOVELTY, DOPAMINE AND RESPONSE TO AMPHETAMINE
新奇、多巴胺和对安非他明的反应
  • 批准号:
    6362851
  • 财政年份:
    2000
  • 资助金额:
    $ 21.34万
  • 项目类别:

相似国自然基金

greenwashing behavior in China:Basedon an integrated view of reconfiguration of environmental authority and decoupling logic
  • 批准号:
  • 批准年份:
    2024
  • 资助金额:
    万元
  • 项目类别:
    外国学者研究基金项目

相似海外基金

The role of VMAT-2 in mediating the impact of HIV-1 protein Tat and methamphetamine on dopamine neurotransmission and behavior
VMAT-2在介导HIV-1蛋白Tat和甲基苯丙胺对多巴胺神经传递和行为的影响中的作用
  • 批准号:
    10547890
  • 财政年份:
    2023
  • 资助金额:
    $ 21.34万
  • 项目类别:
Role of cortical catecholamines in regulating motivated behavior and striatal dopamine
皮质儿茶酚胺在调节动机行为和纹状体多巴胺中的作用
  • 批准号:
    10659716
  • 财政年份:
    2023
  • 资助金额:
    $ 21.34万
  • 项目类别:
Induction of courageous behavior by modulation of dopamine release in the brain
通过调节大脑中多巴胺的释放来诱导勇敢行为
  • 批准号:
    23K18256
  • 财政年份:
    2023
  • 资助金额:
    $ 21.34万
  • 项目类别:
    Grant-in-Aid for Challenging Research (Exploratory)
Resolving the impact of a human KCNQ3 mutation on mesostriatal dopamine connectivity and striatal network dynamics in social behavior
解决人类 KCNQ3 突变对社会行为中纹状体多巴胺连接和纹状体网络动态的影响
  • 批准号:
    10384357
  • 财政年份:
    2022
  • 资助金额:
    $ 21.34万
  • 项目类别:
Resolving the impact of a human KCNQ3 mutation on mesostriatal dopamine connectivity and striatal network dynamics in social behavior
解决人类 KCNQ3 突变对社会行为中纹状体多巴胺连接和纹状体网络动态的影响
  • 批准号:
    10594900
  • 财政年份:
    2022
  • 资助金额:
    $ 21.34万
  • 项目类别:
Subcellular Mapping and Post-Synaptic Impacts of Striatal Dopamine Release During Behavior
行为过程中纹状体多巴胺释放的亚细胞映射和突触后影响
  • 批准号:
    10615333
  • 财政年份:
    2022
  • 资助金额:
    $ 21.34万
  • 项目类别:
Dopamine Neuronal Microcircuits Controlling Methamphetamine Seeking Behavior
多巴胺神经元微电路控制甲基苯丙胺寻求行为
  • 批准号:
    10440637
  • 财政年份:
    2021
  • 资助金额:
    $ 21.34万
  • 项目类别:
Allopregnanolone regulation of phasic dopamine release and motivated behavior
四氢孕酮对阶段性多巴胺释放和动机行为的调节
  • 批准号:
    10491710
  • 财政年份:
    2021
  • 资助金额:
    $ 21.34万
  • 项目类别:
Roles of dopamine D5 receptors in the medial prefrontal cortex on the control of impulsive behavior
内侧前额叶皮层多巴胺 D5 受体在控制冲动行为中的作用
  • 批准号:
    21K20856
  • 财政年份:
    2021
  • 资助金额:
    $ 21.34万
  • 项目类别:
    Grant-in-Aid for Research Activity Start-up
Dopamine Neuronal Microcircuits Controlling Methamphetamine Seeking Behavior
多巴胺神经元微电路控制甲基苯丙胺寻求行为
  • 批准号:
    10591238
  • 财政年份:
    2021
  • 资助金额:
    $ 21.34万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了